The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

In this report, we summarize the findings of 10 phase 3 and 4 clinical studies evaluating coadministration of the quadrivalent meningococcal conjugate vaccine MenACWY-CRM with a number of vaccines ...

The MenACWY vaccine uses parts of the sugar capsule within each of the bacteria and joins them to a protein. This is called a "conjugate vaccine" and allows for a better immune response, especially in ...

Since the rollout of the conjugate MenC vaccine in 2001 and the MenACWY in 2018, rates of invasive meningococcal disease have dropped dramatically, from 684 cases in 2002, to 136 cases in 2024.

Committee won’t take up HPV or meningococcal vaccines Missing from the agenda are some heavily researched vaccine policy proposals the advisers were supposed to consider this month, including shots ...

No longer included are discussions on cytomegalovirus vaccine, human papillomavirus (HPV) vaccine, Lyme disease vaccine, meningococcal vaccine and pneumococcal vaccines.

The Business Research Company's Meningococcal Disease Vaccine Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Latest Report ...

It’s not clear what the discussion and vote at next week’s meeting on thimerosal in flu vaccines will entail, and the presenter of the information at the meeting is listed on the agenda as “TBD.” A ...

U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers meet next week. Their agenda suggests they’ll skip some expected topics, including a vote on COVID-19 shots. But they will ...